IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest DEFA14A SEC Filings
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
AQUILA BIOPHARMACEUTICALS INC, DEFA14A, 2000-10-31
AQUILA BIOPHARMACEUTICALS INC, DEFA14A, 2000-10-20
TECHNICAL CHEMICALS & PRODUCTS INC, DEFA14A, 2000-06-16
HEMAGEN DIAGNOSTICS INC, DEFA14A, 1999-09-08
HEMAGEN DIAGNOSTICS INC, DEFA14A, 1999-08-24
HEMAGEN DIAGNOSTICS INC, DEFA14A, 1999-08-09
HEMAGEN DIAGNOSTICS INC, DEFA14A, 1999-07-27
HEMAGEN DIAGNOSTICS INC, DEFA14A, 1999-07-16
HEMAGEN DIAGNOSTICS INC, DEFA14A, 1999-07-01
EPOCH PHARMACEUTICALS INC, DEFA14A, 1998-04-23
TECHNICLONE CORP/DE/, DEFA14A, 1997-10-03
EPITOPE INC/OR/, DEFA14A, 1997-06-03
EPITOPE INC/OR/, DEFA14A, 1997-05-28
AQUILA BIOPHARMACEUTICALS INC, DEFA14A, 1997-05-05
EPITOPE INC/OR/, DEFA14A, 1997-03-18
GOLDEN PHARMACEUTICALS INC, DEFA14A, 1997-01-15
EPOCH PHARMACEUTICALS INC, DEFA14A, 1996-09-16
GENOME THERAPEUTICS CORP, DEFA14A, 1996-01-09
CYTOGEN CORP, DEFA14A, 1995-09-19
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
